Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Davis

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|December 31, 2011
Taking a practical approachJan Davis
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|April 20, 2006
Nurse case management for pregnant women experiencing or at risk for abuseMary Ann Curry, Laurel Durham, Linda Bullock, et al.
Journal of Midwifery & Women'S Health|September 2, 2006
Abuse disclosure in privately and medicaid-funded pregnant womenLinda Bullock, Tina Bloom, Jan Davis, et al.
Journal of Intellectual Disabilities : JOID|July 13, 2022
An integrated practical placement programme for students with disability: A pilot studyDebra Kiegaldie, Louise Shaw, Stuart Hunter, et al.
Haematologica|August 6, 2002
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromesGuillermo Garcia-Manero, Stefan Faderl, Francis Giles, et al.
Canadian Journal of Kidney Health and Disease|October 22, 2019
Facility Variation and Predictors of Do Not Resuscitate Orders of Hemodialysis Patients in Canada: DOPPSDanielle Moorman, Ranjeeta Mallick, Emily Rhodes, et al.
Indian Journal of Pediatrics|August 30, 2018
Immunodeficiency in a Child with Alström SyndromeTaha Resid Ozdemir, Neslihan Edeer Karaca, Jan Davis Marshall, et al.
Blood|June 7, 2003
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaHagop Kantarjian, Varsha Gandhi, Jorge Cortes, et al.
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|December 31, 2011
Taking a practical approachJan Davis
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|April 20, 2006
Nurse case management for pregnant women experiencing or at risk for abuseMary Ann Curry, Laurel Durham, Linda Bullock, et al.
Journal of Midwifery & Women'S Health|September 2, 2006
Abuse disclosure in privately and medicaid-funded pregnant womenLinda Bullock, Tina Bloom, Jan Davis, et al.
Journal of Intellectual Disabilities : JOID|July 13, 2022
An integrated practical placement programme for students with disability: A pilot studyDebra Kiegaldie, Louise Shaw, Stuart Hunter, et al.
Haematologica|August 6, 2002
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromesGuillermo Garcia-Manero, Stefan Faderl, Francis Giles, et al.
Canadian Journal of Kidney Health and Disease|October 22, 2019
Facility Variation and Predictors of Do Not Resuscitate Orders of Hemodialysis Patients in Canada: DOPPSDanielle Moorman, Ranjeeta Mallick, Emily Rhodes, et al.
Indian Journal of Pediatrics|August 30, 2018
Immunodeficiency in a Child with Alström SyndromeTaha Resid Ozdemir, Neslihan Edeer Karaca, Jan Davis Marshall, et al.
Blood|June 7, 2003
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaHagop Kantarjian, Varsha Gandhi, Jorge Cortes, et al.
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
Pageof 1